BioCentury
ARTICLE | Clinical News

AZD2811: Phase I started

December 7, 2015 8:00 AM UTC

AstraZeneca began an open-label, U.S. Phase I trial to evaluate AZD2811 in about 77 patients. A dose-escalation part will determine the dose for the dose-expansion part, which will evaluate AZD2811 al...